Page last updated: 2024-12-10

7-hydroxycoumarin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

7-oxycoumarin: derivatives have anti-oxidant properties [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

umbelliferone : A hydroxycoumarin that is coumarin substituted by a hydroxy group ay position 7. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5281426
CHEMBL ID51628
CHEBI ID27510
SCHEMBL ID22018
MeSH IDM0098875

Synonyms (115)

Synonym
BIDD:PXR0126
AC-18399
BIDD:ER0671
BB 0218364
BRD-K87991767-001-02-0
BRD-K87991767-001-03-8
CHEBI:27510 ,
beta-umbelliferone
NCI60_001646
SDCCGMLS-0066941.P001
ccris 3591
nsc 19790
ai3-38054
einecs 202-240-3
brn 0127683
BSPBIO_002362
nsc19790 ,
7 hc
skimmetin
hydrangine
nsc-19790
2h-1-benzopyran-2-one, 7-hydroxy-
hydrangin
skimmetine
.beta.-umbelliferone
umbelliferon
coumarin, 7-hydroxy-
7-oxycoumarin
NCGC00178691-01
NCGC00178691-02
7-hydroxychromen-2-one
7-hydroxy-2h-1-benzopyran-2-one
inchi=1/c9h6o3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10
7-hydroxy-2h-chromen-2-one
7-hydroxycoumarin ,
93-35-6
C09315
umbelliferone
umbelliferone, 99%
ACON1_000219
MEGXP0_000814
NCGC00095801-01
KBIO3_001582
SPECTRUM3_000751
SPECTRUM2_001962
SPBIO_002083
SPECTRUM231084
7-hydroxy coumarin
7-hydroxycoumarin, 14c-labeled
U-3000
STK331042
7-hydroxy-1-benzopyran-2-one
umbelliferone, suitable for fluorescence indicator, >=98.0% (hplc)
7-hc
smr000112324
MLS002207035
CHEMBL51628 ,
nsc-019790
HMS1607M21
coumarin derivative, 3a
bdbm50174558
H0236
AKOS000120867
7-oxidanylchromen-2-one
A801734
A844525
NCGC00095801-02
NCGC00095801-03
7-hydroxycoumarine
60z60ntl4g ,
unii-60z60ntl4g
5-18-01-00386 (beilstein handbook reference)
07l ,
HMS2271N09
S3675
CCG-39436
FT-0621430
32922-68-2
umbelliferone [who-dd]
7 oh coumarin
umbelliferone [mi]
BBL027620
SCHEMBL22018
7-hydroxycournarin
7-hydroxy-coumarin
7-hydroxy-chromen-2-one
7-hydroxycumarin
DTXSID5052626 ,
7-hydroxy-2h-chromen-2-one #
7-hydroxy-2-chromenone
STR04824
AC-34707
mfcd00006878
F0722-0129
CS-D1186
umbelliferone, analytical standard
umbelliferone, vetec(tm) reagent grade, 98%
umbelliferone; 7-hydroxy-2h-1-benzopyran-2-one; 7-oxycoumarin; hydrangin; skimmetin
beta -umbelliferone
7-hydroxycoumarin sulphate
umbelliferone (hydrangin, skimmetin)
HY-N0573
SY001924
Z57150899
Q416196
7-hydroxy coumarin ,(s)
142044-47-1
dichrin a
A14827
HMS3741M03
2-hydroxy-7h-chromen-7-one
7-hydroxy-coumarine
EN300-18075
7-hydroxycoumarin;hydrangin;nsc 19790
dtxcid9031199

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The purpose of the present in vitro study was to determine the concentrations of coumarin and 7-hydroxycoumarin (7-HC) that would be toxic to human peripheral blood mononuclear cells (PB-MNC) and human and murine bone marrow (GM) progenitor stem cells."( Toxicity of coumarin (1,2-benzopyrone) on human peripheral blood mononuclear cells and human and murine bone marrow progenitor stem cells.
Gallicchio, VS; Harmon, C; Hulette, BC; Marshall, ME, 1989
)
0.5

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic profile of C as well as the metabolic 7-hydroxylation and glucuronidation found in the blood of the gerbil is similar to that found in man."( Pharmacokinetics of coumarin, 7-hydroxycoumarin and 7-hydroxycoumarin glucuronide in the blood and brain of gerbils following intraperitoneal administration of coumarin.
Hardt, TJ; Ritschel, WA, 1983
)
0.55
" Coumarin blood levels were fit to pharmacokinetic models using computer programs including NONLIN, modified ESTRIP, RESID and AUCRPP."( Dose-related pharmacokinetics of coumarin, 7-hydroxycoumarin and 7-hydroxycoumarin glucuronide upon intraperitoneal administration of coumarin and 7-hydroxycoumarin in the rat.
Hardt, TJ; Ritschel, WA, 1983
)
0.53
"The absorption, distribution, metabolism, and excretion (ADME) and the pharmacokinetic characteristics of BMS-562086 [pexacerfont; 8-(6-methoxy-2-methyl-3-pyridinyl)-2,7-dimethyl-N-[(1R)-1-methylpropyl]pyrazolo(1,5-a)-1,3,5-triazin-4-amine (DPC-A69448)] were investigated in vitro and in animals to support its clinical development."( In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist.
Dockens, RC; Grossman, SJ; Iyer, RA; Liu-Kreyche, P; Zhou, L, 2012
)
0.38
" Since herbal medicine (HM) is a synergistical system with multiple components, both of the metabolism and pharmacokinetic studies of HM are interdependent."( An integrated strategy based on UPLC-DAD-QTOF-MS for metabolism and pharmacokinetic studies of herbal medicines: Tibetan "Snow Lotus" herb (Saussurea laniceps), a case study.
Bian, ZX; Chen, HB; Liang, ZT; Tang, YN; Xu, J; Yang, ZJ; Yi, T; Yu, ZL; Zhang, JY; Zhao, ZZ; Zhu, L, 2014
)
0.4
" Their pharmacokinetic parameters were measured and biotransformation pathways were elucidated."( An integrated strategy based on UPLC-DAD-QTOF-MS for metabolism and pharmacokinetic studies of herbal medicines: Tibetan "Snow Lotus" herb (Saussurea laniceps), a case study.
Bian, ZX; Chen, HB; Liang, ZT; Tang, YN; Xu, J; Yang, ZJ; Yi, T; Yu, ZL; Zhang, JY; Zhao, ZZ; Zhu, L, 2014
)
0.4
" Literature reports also suggest that umbelliferone and scopoletin are responsible for the therapeutic effects of SL, thus these two components were selected as the active markers for pharmacokinetic study."( An integrated strategy based on UPLC-DAD-QTOF-MS for metabolism and pharmacokinetic studies of herbal medicines: Tibetan "Snow Lotus" herb (Saussurea laniceps), a case study.
Bian, ZX; Chen, HB; Liang, ZT; Tang, YN; Xu, J; Yang, ZJ; Yi, T; Yu, ZL; Zhang, JY; Zhao, ZZ; Zhu, L, 2014
)
0.4
"The present strategy offers, simultaneously, precision in quantitative analysis (metabolism study) and accuracy in quantitative analysis (pharmacokinetic study) with greater efficiency and less costs, which is therefore reliably used for integrated metabolism and pharmacokinetic studies of HM."( An integrated strategy based on UPLC-DAD-QTOF-MS for metabolism and pharmacokinetic studies of herbal medicines: Tibetan "Snow Lotus" herb (Saussurea laniceps), a case study.
Bian, ZX; Chen, HB; Liang, ZT; Tang, YN; Xu, J; Yang, ZJ; Yi, T; Yu, ZL; Zhang, JY; Zhao, ZZ; Zhu, L, 2014
)
0.4
" For human physiologically based pharmacokinetic (PBPK) modeling, the metabolic ratios to o-hydroxyphenylacetic acid and 7-hydroxycoumarin were set at minor (0."( Metabolic profiles of coumarin in human plasma extrapolated from a rat data set with a simplified physiologically based pharmacokinetic model.
Hina, S; Kamiya, Y; Kobayashi, Y; Miura, T; Murayama, N; Shimizu, M; Yamazaki, H, 2020
)
0.77

Compound-Compound Interactions

ExcerptReferenceRelevance
" Therefore, the aim of our study was to investigate the effect of simple coumarins (osthole, umbelliferone, esculin, and 4-hydroxycoumarin) combined with sorafenib (specific inhibitor of Raf (Rapidly Accelerated Fibrosarcoma) kinase) in programmed death induction in human glioblastoma multiforme (T98G) and anaplastic astrocytoma (MOGGCCM) cells lines."( Antiglioma Potential of Coumarins Combined with Sorafenib.
Jakubowicz-Gil, J; Langner, E; Maciejczyk, A; Rzeski, W; Skalicka-Woźniak, K; Sumorek-Wiadro, J; Zając, A, 2020
)
0.56

Bioavailability

ExcerptReferenceRelevance
" When the prolonged-release dosage form was compared to the peroral solution, the extent of bioavailability of coumarin was 35 per cent, whereas the 7-hydroxycoumarin glucuronide was totally available."( Pilot study on bioavailability of coumarin and 7-hydroxycoumarin upon peroral administration of coumarin in a sustained-release dosage form.
Hoffmann, KA; Ritschel, WA, 1981
)
0.72
"Grapefruit juice has been shown to enhance oral bioavailability of several drugs including coumarin."( Naringenin and interindividual variability in interaction of coumarin with grapefruit juice.
Bourian, M; Freudenstein, J; Krisp, A; Legrum, W; Runkel, M; Tegtmeier, M, 1999
)
0.3
" In this context, the question was raised whether coumarin in the plant matrix of cinnamon has the same bioavailability as isolated coumarin."( Relative bioavailability of coumarin from cinnamon and cinnamon-containing foods compared to isolated coumarin: a four-way crossover study in human volunteers.
Abraham, K; Lampen, A; Pfister, M; Wöhrlin, F, 2011
)
0.37
" BMS-562086 was orally bioavailable in rats, dogs, and chimpanzees, with an absolute oral bioavailability of 40."( In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist.
Dockens, RC; Grossman, SJ; Iyer, RA; Liu-Kreyche, P; Zhou, L, 2012
)
0.38
" Subsequent optimization and removal of the 7-hydroxy group led to coumarin 59, which had increased potency and improved rat bioavailability relative to SS5020."( Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-Regulators.
Bailey, A; Callis, R; De Savi, C; Degorce, SL; Ducray, R; Lamont, G; MacFaul, P; Martin, S; Maudet, M; Morgentin, R; Norman, RA; Peru, A; Pink, JH; Plé, PA; Roberts, B; Scott, JS, 2015
)
0.42
"Among the compounds assayed, auraptene showed to possess potentialities to be a potent activator of both translocation of GLUT4 and glucose influx into skeletal muscle cells with the highest bioavailability among effective compounds."( The interaction of auraptene and other oxyprenylated phenylpropanoids with glucose transporter type 4.
Ashida, H; Daishi, S; Epifano, F; Fiorito, S; Genovese, S; Ikeda, M; Nakgano, T; Taddeo, VA; Yamashita, Y, 2017
)
0.46

Dosage Studied

Coumarin (C) and 7-hydroxycou marin (7HC) were tested in rats. Carrageenan induced edema of the hind paw was used to measure dose-response relationship. When the prolonged-release dosage form was compared to the peroral solution, the extent of bioavailability of coumarin was 35 per cent.

ExcerptRelevanceReference
" The patients were on 7:00 h-13:00 h-19:00 h dosage regimen of 2 controlled release tablets (Venalot Depot; 15 mg C per tablet)."( Therapeutic concentration of coumarin and predicted dosage regimens.
Ritschel, WA, 1984
)
0.27
" Upon 7HC dosing only 7HC, 7HCG and 7HCS were detected in any organ."( Tissue distribution of coumarin, 7-hydroxycoumarin and their 7-hydroxy metabolites following parenteral administration of 14C-labeled compound in the DBA/lac mouse.
Hardt, T; Ritschel, WA, 1983
)
0.55
" 7-HC levels upon 7-HC dosing were found to have extremely short half-lives of elimination for all animals tested."( Dose-related pharmacokinetics of coumarin, 7-hydroxycoumarin and 7-hydroxycoumarin glucuronide upon intraperitoneal administration of coumarin and 7-hydroxycoumarin in the rat.
Hardt, TJ; Ritschel, WA, 1983
)
0.53
"The dose-response relationship upon intraperitoneal administration of coumarin (C) and 7-hydroxycoumarin (7HC) in rats was evaluated using the carrageenan induced edema of the hind paw."( Investigation of the dose-response relationship upon intraperitoneal administration of coumarin and 7-hydroxycoumarin on the carrageenan induced edema of the rat hind paw.
Hardt, TJ; Ritschel, WA, 1983
)
0.7
" When the prolonged-release dosage form was compared to the peroral solution, the extent of bioavailability of coumarin was 35 per cent, whereas the 7-hydroxycoumarin glucuronide was totally available."( Pilot study on bioavailability of coumarin and 7-hydroxycoumarin upon peroral administration of coumarin in a sustained-release dosage form.
Hoffmann, KA; Ritschel, WA, 1981
)
0.72
" Urine samples were collected up to 24 h after dosing and 7-hydroxycoumarin was quantified fluorimetrically in urine hydrolysates after HPLC separation to determine the excretion rates."( The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human.
Bourian, M; Legrum, W; Runkel, M; Tegtmeier, M, 1997
)
0.54
" Single compound, 7-hydroxycoumarin (7-HC), along with necessary cofactors was dosed into the matrices and incubated at 37 degrees C; formation of two metabolites, 7-HC-glucuronide and 7-HC-sulfate, was determined with liquid chromatography with tandem mass spectrometry."( Glucuronidation and sulfation of 7-hydroxycoumarin in liver matrices from human, dog, monkey, rat, and mouse.
Garcia, M; Hidalgo, IJ; Jia, R; Li, J; Wang, Q; Ye, C,
)
0.75
"0 h, respectively and there was evidence that the recommended dosage of guaco syrup did not provide sufficient levels of COU, 7-HCOU or OCA to obtain a bronchodilation effect."( A kinetic study of the main guaco metabolites using syrup formulation and the identification of an alternative route of coumarin metabolism in humans.
Campos, FR; Cerqueira, LB; de Francisco, TM; Gasparetto, JC; Peccinini, RG; Pontarolo, R, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
fluorescent probeA role played by a fluorescent molecular entity used to study the microscopic environment by fluorescence spectroscopy.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
food componentA physiological role played by any substance that is distributed in foodstuffs. It includes materials derived from plants or animals, such as vitamins or minerals, as well as environmental contaminants.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydroxycoumarinAny coumarin carrying at least one hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (13)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase I - Functionalization of compounds69175
Cytochrome P450 - arranged by substrate type30110
Xenobiotics450
simple coumarins biosynthesis2221
simplecoumarins biosynthesis620
coumarins biosynthesis (engineered)628
superpathway of scopolin and esculin biosynthesis127
umbelliferone biosynthesis113
linear furanocoumarin biosynthesis120
umbelliferone biosynthesis114
coumarins biosynthesis (engineered)831
linear furanocoumarin biosynthesis221
superpathway of scopolin and esculin biosynthesis131
superpathway of dimethylsulfone degradation219
dimethyl sulfide degradation I217
simple coumarins biosynthesis2823
Linear furanocoumarin biosynthesis015

Protein Targets (45)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency50.11870.004023.8416100.0000AID485290
Chain A, HADH2 proteinHomo sapiens (human)Potency25.11890.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency25.11890.025120.237639.8107AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency14.12540.177814.390939.8107AID2147
Chain A, Ferritin light chainEquus caballus (horse)Potency39.81075.623417.292931.6228AID485281
Chain A, CruzipainTrypanosoma cruziPotency39.81070.002014.677939.8107AID1476
thioredoxin reductaseRattus norvegicus (Norway rat)Potency67.83350.100020.879379.4328AID588453; AID588456
GLS proteinHomo sapiens (human)Potency12.58930.35487.935539.8107AID624170
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency28.18380.011212.4002100.0000AID1030
glucocerebrosidaseHomo sapiens (human)Potency28.18380.01268.156944.6684AID2101
alpha-galactosidaseHomo sapiens (human)Potency35.48134.466818.391635.4813AID1467; AID2107
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency31.62280.036619.637650.1187AID2112
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency28.18380.001815.663839.8107AID894
chromobox protein homolog 1Homo sapiens (human)Potency56.23410.006026.168889.1251AID540317
importin subunit beta-1 isoform 1Homo sapiens (human)Potency112.20205.804836.130665.1308AID540263
flap endonuclease 1Homo sapiens (human)Potency100.00000.133725.412989.1251AID588795
snurportin-1Homo sapiens (human)Potency112.20205.804836.130665.1308AID540263
gemininHomo sapiens (human)Potency20.59620.004611.374133.4983AID624296
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency39.81070.251215.843239.8107AID504327
caspase-1 isoform alpha precursorHomo sapiens (human)Potency19.95260.000311.448431.6228AID900
Caspase-7Homo sapiens (human)Potency15.84893.981118.585631.6228AID889
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseElectrophorus electricus (electric eel)IC50 (µMol)140.00000.00000.94539.9400AID754043
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)420.00000.03403.987110.0000AID1760262
Carbonic anhydrase 12Homo sapiens (human)Ki0.51640.00021.10439.9000AID1274834; AID1348314; AID641826
Carbonic anhydrase 1Homo sapiens (human)Ki46.30000.00001.372610.0000AID1274831; AID1348311; AID539679; AID641823
Carbonic anhydrase 2Homo sapiens (human)Ki77.50000.00000.72369.9200AID1274832; AID1348312; AID539680; AID641824
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)IC50 (µMol)616.59506.00007.33338.0000AID75720
Seed linoleate 13S-lipoxygenase-1Glycine max (soybean)IC50 (µMol)43.00000.07002.12673.5000AID255039
TyrosinaseHomo sapiens (human)IC50 (µMol)420.00000.02304.459310.0000AID598386
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)22.90000.00101.191310.0000AID516862
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)14,550.00000.00000.933210.0000AID360659; AID758230
Xanthine dehydrogenase/oxidaseHomo sapiens (human)IC50 (µMol)236.00000.00132.81389.8200AID294445
Beta-secretase 1Homo sapiens (human)IC50 (µMol)500.00000.00061.619410.0000AID637774
Small conductance calcium-activated potassium channel protein 3Rattus norvegicus (Norway rat)IC50 (µMol)500.00000.00151.68587.0000AID754042
CholinesteraseEquus caballus (horse)IC50 (µMol)500.00000.00002.22149.4000AID754042
Sorbitol dehydrogenaseHomo sapiens (human)IC50 (µMol)120.00000.24000.49531.0000AID516864
Induced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)IC50 (µMol)21.04000.00442.923510.0000AID1701173
Induced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)Ki3.81000.00101.46539.5400AID1701173
Carbonic anhydrase 9Homo sapiens (human)Ki0.36620.00010.78749.9000AID1274833; AID1348313; AID539681; AID641825
Zn finger protein Nicotiana tabacum (common tobacco)Ki0.75400.75400.75400.7540AID539682
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ERAP1 proteinHomo sapiens (human)AC5012.14000.73006.753312.1400AID743314
Carbonic anhydrase 12Homo sapiens (human)Kinact0.75400.00300.66749.6000AID493457
Carbonic anhydrase 1Homo sapiens (human)Kinact58.40000.01000.93878.6000AID493454
Carbonic anhydrase 2Homo sapiens (human)Kinact100.00000.00300.794610.0000AID493455
Substance-P receptorCavia porcellus (domestic guinea pig)CD500.00000.90004.50009.8000AID144377
Quinone oxidoreductaseMus musculus (house mouse)CD500.00000.20002.74219.8000AID144377
Carbonic anhydrase 9Homo sapiens (human)Kinact0.48200.00500.31976.6700AID493456
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (148)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
microtubule cytoskeleton organizationGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
positive regulation of cytokine productionGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
glucose metabolic processGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
glycolytic processGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
negative regulation of endopeptidase activityGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
regulation of macroautophagyGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
negative regulation of translationGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
killing of cells of another organismGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
positive regulation of type I interferon productionGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
peptidyl-cysteine S-trans-nitrosylationGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
protein stabilizationGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
defense response to fungusGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
neuron apoptotic processGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
killing by host of symbiont cellsGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptideGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
cellular response to type II interferonGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
allantoin metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell proliferationXanthine dehydrogenase/oxidaseHomo sapiens (human)
guanine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
inosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyinosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
adenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyadenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyguanosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
AMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
IMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
lactationXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of gene expressionXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron-sulfur cluster assemblyXanthine dehydrogenase/oxidaseHomo sapiens (human)
amide catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell differentiationXanthine dehydrogenase/oxidaseHomo sapiens (human)
GMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dGMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dAMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of p38MAPK cascadeXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vasculogenesisXanthine dehydrogenase/oxidaseHomo sapiens (human)
proteolysisCaspase-7Homo sapiens (human)
apoptotic processCaspase-7Homo sapiens (human)
heart developmentCaspase-7Homo sapiens (human)
response to UVCaspase-7Homo sapiens (human)
protein processingCaspase-7Homo sapiens (human)
protein catabolic processCaspase-7Homo sapiens (human)
defense response to bacteriumCaspase-7Homo sapiens (human)
fibroblast apoptotic processCaspase-7Homo sapiens (human)
striated muscle cell differentiationCaspase-7Homo sapiens (human)
neuron apoptotic processCaspase-7Homo sapiens (human)
protein maturationCaspase-7Homo sapiens (human)
lymphocyte apoptotic processCaspase-7Homo sapiens (human)
cellular response to lipopolysaccharideCaspase-7Homo sapiens (human)
cellular response to staurosporineCaspase-7Homo sapiens (human)
execution phase of apoptosisCaspase-7Homo sapiens (human)
positive regulation of plasma membrane repairCaspase-7Homo sapiens (human)
positive regulation of neuron apoptotic processCaspase-7Homo sapiens (human)
proteolysisBeta-secretase 1Homo sapiens (human)
membrane protein ectodomain proteolysisBeta-secretase 1Homo sapiens (human)
response to lead ionBeta-secretase 1Homo sapiens (human)
protein processingBeta-secretase 1Homo sapiens (human)
amyloid-beta formationBeta-secretase 1Homo sapiens (human)
amyloid precursor protein catabolic processBeta-secretase 1Homo sapiens (human)
positive regulation of neuron apoptotic processBeta-secretase 1Homo sapiens (human)
amyloid-beta metabolic processBeta-secretase 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painBeta-secretase 1Homo sapiens (human)
prepulse inhibitionBeta-secretase 1Homo sapiens (human)
cellular response to copper ionBeta-secretase 1Homo sapiens (human)
cellular response to manganese ionBeta-secretase 1Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionBeta-secretase 1Homo sapiens (human)
signaling receptor ligand precursor processingBeta-secretase 1Homo sapiens (human)
cellular response to amyloid-betaBeta-secretase 1Homo sapiens (human)
amyloid fibril formationBeta-secretase 1Homo sapiens (human)
glucose metabolic processSorbitol dehydrogenaseHomo sapiens (human)
sorbitol catabolic processSorbitol dehydrogenaseHomo sapiens (human)
glucuronate catabolic process to xylulose 5-phosphateSorbitol dehydrogenaseHomo sapiens (human)
flagellated sperm motilitySorbitol dehydrogenaseHomo sapiens (human)
fructose biosynthetic processSorbitol dehydrogenaseHomo sapiens (human)
L-xylitol catabolic processSorbitol dehydrogenaseHomo sapiens (human)
L-xylitol metabolic processSorbitol dehydrogenaseHomo sapiens (human)
DNA damage responseInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
response to cytokineInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cell fate determinationInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of autophagyInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cellular homeostasisInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
positive regulation of apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein transmembrane transportInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of anoikisInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial fusionInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
release of cytochrome c from mitochondriaInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (66)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activityGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
protein bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
microtubule bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
aspartic-type endopeptidase inhibitor activityGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
peptidyl-cysteine S-nitrosylase activityGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
identical protein bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
NADP bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
NAD bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
disordered domain specific bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron ion bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein homodimerization activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
FAD bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
RNA bindingCaspase-7Homo sapiens (human)
aspartic-type endopeptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-7Homo sapiens (human)
protein bindingCaspase-7Homo sapiens (human)
peptidase activityCaspase-7Homo sapiens (human)
cysteine-type peptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic processCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in execution phase of apoptosisCaspase-7Homo sapiens (human)
amyloid-beta bindingBeta-secretase 1Homo sapiens (human)
endopeptidase activityBeta-secretase 1Homo sapiens (human)
aspartic-type endopeptidase activityBeta-secretase 1Homo sapiens (human)
protein bindingBeta-secretase 1Homo sapiens (human)
peptidase activityBeta-secretase 1Homo sapiens (human)
beta-aspartyl-peptidase activityBeta-secretase 1Homo sapiens (human)
enzyme bindingBeta-secretase 1Homo sapiens (human)
protein serine/threonine kinase bindingBeta-secretase 1Homo sapiens (human)
(R,R)-butanediol dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
L-iditol 2-dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
zinc ion bindingSorbitol dehydrogenaseHomo sapiens (human)
carbohydrate bindingSorbitol dehydrogenaseHomo sapiens (human)
identical protein bindingSorbitol dehydrogenaseHomo sapiens (human)
D-xylulose reductase activitySorbitol dehydrogenaseHomo sapiens (human)
D-sorbitol dehydrogenase (acceptor) activitySorbitol dehydrogenaseHomo sapiens (human)
ribitol 2-dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
NAD bindingSorbitol dehydrogenaseHomo sapiens (human)
protein bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein transmembrane transporter activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein heterodimerization activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
BH3 domain bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
channel activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
BH domain bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (56)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
nucleusGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
cytoplasmGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
lipid dropletGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
cytosolGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
plasma membraneGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
microtubule cytoskeletonGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
membraneGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
nuclear membraneGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
vesicleGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
intracellular membrane-bounded organelleGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
perinuclear region of cytoplasmGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
extracellular exosomeGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
GAIT complexGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
ribonucleoprotein complexGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
cytosolGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
peroxisomeXanthine dehydrogenase/oxidaseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
sarcoplasmic reticulumXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
cytoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
nucleoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
lysosomeBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
early endosomeBeta-secretase 1Homo sapiens (human)
late endosomeBeta-secretase 1Homo sapiens (human)
multivesicular bodyBeta-secretase 1Homo sapiens (human)
endoplasmic reticulum lumenBeta-secretase 1Homo sapiens (human)
Golgi apparatusBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
synaptic vesicleBeta-secretase 1Homo sapiens (human)
cell surfaceBeta-secretase 1Homo sapiens (human)
endosome membraneBeta-secretase 1Homo sapiens (human)
membraneBeta-secretase 1Homo sapiens (human)
axonBeta-secretase 1Homo sapiens (human)
dendriteBeta-secretase 1Homo sapiens (human)
neuronal cell bodyBeta-secretase 1Homo sapiens (human)
membrane raftBeta-secretase 1Homo sapiens (human)
recycling endosomeBeta-secretase 1Homo sapiens (human)
Golgi-associated vesicle lumenBeta-secretase 1Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
extracellular spaceSorbitol dehydrogenaseHomo sapiens (human)
cytosolSorbitol dehydrogenaseHomo sapiens (human)
membraneSorbitol dehydrogenaseHomo sapiens (human)
motile ciliumSorbitol dehydrogenaseHomo sapiens (human)
mitochondrial membraneSorbitol dehydrogenaseHomo sapiens (human)
extracellular exosomeSorbitol dehydrogenaseHomo sapiens (human)
nucleusInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
nucleoplasmInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytoplasmInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrionInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytosolInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
Bcl-2 family protein complexInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (301)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1218611Detection of compound level in rat hepatocytes treated with 25 uM of BMS-562086 after 3 hrs by HPLC analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist.
AID1563163Half-life in dog hepatocytes2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
(
AID599337Antibacterial against Escherichia coli ATCC 10536 at 20 mg/mL after 24 hrs by NCCLS M7-A6 method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin.
AID1701173Displacement of FAM-Bid peptide from recombinant N-terminal His6x-tagged human Mcl-1 expressed in Escherichia coli BL21 (DE3) incubated for 30 mins by fluorescence polarization assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment.
AID392745Antioxidant activity assessed as DPPH radical scavenging activity at 0.01 mM after 60 mins2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Synthesis of hydroxycoumarins and hydroxybenzo[f]- or [h]coumarins as lipid peroxidation inhibitors.
AID1213503Activity at MRP3 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed-phase HPLC analysis in presence of ATP2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
AID1359333Induction of melanogenesis in mouse Melan-a cells assessed as effect on tanning property at 40 uM after 48 hrs2018European journal of medicinal chemistry, May-25, Volume: 152Natural oxyprenylated coumarins are modulators of melanogenesis.
AID1385470Antiausteritic activity against human PSN1 cells in nutrient-deprived medium measured after 24 hrs by WST8 assay2018Journal of natural products, 08-24, Volume: 81, Issue:8
Chemical Constituents of Thai Citrus hystrix and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line.
AID1359331Cytotoxicity against mouse Melan-a cells assessed as effect on cell viability at 40 uM after 24 to 72 hrs by trypan blue exclusion assay2018European journal of medicinal chemistry, May-25, Volume: 152Natural oxyprenylated coumarins are modulators of melanogenesis.
AID754043Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 6 mins prior to substrate addition measured at 60 to 180 seconds by Ellman's method2013European journal of medicinal chemistry, Jun, Volume: 64Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
AID687409Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in paw withdrawal response at 60 mg/kg, po dosed once daily for 7 days dosed 45 mins before complete Freund's adjuvant dosing measured post complete Freund's adjuvant ch2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID332867Cytotoxicity against mouse P388 cells
AID256454Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 4 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID624611Specific activity of expressed human recombinant UGT1A82000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1488614Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
AID1563162Half-life in rat hepatocytes2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
(
AID1265014Activation of Nrf2 in human HSC3-ARE9 cells assessed as increase of ARE-mediated luciferase expression at 50 uM after 24 hrs relative to control2015European journal of medicinal chemistry, Dec-01, Volume: 106Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.
AID607601Cytotoxicity against human U373 cells assessed as growth inhibition at MTT assay-related IC50 by quantitative video microscopy relative to control2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID1899617Metabolic stability in human liver microsomes assessed as CYP-mediated metabolism at 20 uM and measured as half-life by LC-UV analysis2022European journal of medicinal chemistry, Jan-15, Volume: 228Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CL
AID1349248Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition2017Journal of natural products, 12-22, Volume: 80, Issue:12
Regioselective IBX-Mediated Synthesis of Coumarin Derivatives with Antioxidant and Anti-influenza Activities.
AID376057Antimutagenic activity in Salmonella Typhimurium TA100 assessed as protection against benzo[a]pyrene-induced mutation at 4 ug/plate after 2 days by modified Ames test1999Journal of natural products, Oct, Volume: 62, Issue:10
Umbelliferone analogues and their potential to inhibit Benzo(a)pyrene- and hydrogen peroxide-induced mutations.
AID1349251Cytotoxicity against human A549 cells assessed as reduction in cell viability up to 120 ug/ml after 24 hrs by MTT assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Regioselective IBX-Mediated Synthesis of Coumarin Derivatives with Antioxidant and Anti-influenza Activities.
AID1874969Irreversible inhibition of STS in human T47D cells using [3H]E1S as substrate measured after 24 hrs by HPLC analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.
AID1541420Stability in mouse intestinal S9 fractions assessed as phase I and phase II enzymes-mediated generation of systemic metabolites at 0.1 uM incubated at 37 degC for 10 mins by LC-MS/MS analysis
AID613472Inhibition of LPS-stimulated COX2 protein expression in mouse J774 cells at 10 uM by chemiluminescence assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives.
AID624606Specific activity of expressed human recombinant UGT1A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1689278Inhibition of Saccharomyces cerevisiae alpha-glucosidase using PNPG as substrate preincubated for 10 mins followed by substrate addition measured after 30 mins2020European journal of medicinal chemistry, Mar-01, Volume: 189Synthesis and biological evaluation of coumarin derivatives as α-glucosidase inhibitors.
AID516864Inhibition sorbitol dehydrogenase by spectrophotometric analysis2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID637774Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate after 60 mins by fluorescence quenching assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
AID256238Duration of paralysis in rats (injected i.p. with 10 mg/1 mL/g of zoxazolamine) at i.p. dose of 0.001 m mol/kg after 24 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID392744Antioxidant activity assessed as DPPH radical scavenging activity at 0.01 mM after 20 mins2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Synthesis of hydroxycoumarins and hydroxybenzo[f]- or [h]coumarins as lipid peroxidation inhibitors.
AID599332Antibacterial against Bacillus subtilis ATCC 6633 at 20 mg/mL after 24 hrs by NCCLS M7-A6 method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin.
AID1541419Stability in human intestinal S9 fractions assessed as phase I and phase II enzymes-mediated generation of systemic metabolites at 0.1 uM incubated at 37 degC for 10 mins by LC-MS/MS analysis
AID1326357Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 2 weeks2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID1213507Activity at MRP1 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed phase-HPLC analysis in presence of GSH2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
AID599331Antibacterial against Micrococcus luteus ATCC 10240 at 20 mg/mL after 24 hrs by NCCLS M7-A6 method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin.
AID1417124Antitrypanosomal activity against Trypanosoma cruzi Tulahuen C2C4 trypomastigotes infected in rat skeletal myoblasts L-6 cells after 96 hrs by CPRG/Nonidet reagent based spectrophotometric method2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID399962Cytotoxicity against human MCF7 cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Anthrone and oxanthrone C-glycosides from Picramnia latifolia collected in Peru.
AID1677486Antimicrobial activity against Staphylococcus aureus ATCC 6538p2020Journal of natural products, 10-23, Volume: 83, Issue:10
Sortase A-Inhibitory Coumarins from the Folk Medicinal Plant
AID1105461Antifungal activity against Aspergillus fumigatus ATCC 16913 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID687407Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in mechanical hyperalgesia at 30 to 120 mg/kg, po dosed 45 mins before complete Freund's adjuvant dosing measured 24 hrs post complete Freund's adjuvant challenge by ele2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID256457Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 10 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID641826Inhibition of human recombinant CA12 after 6 hrs by stopped flow CO2 hydration assay2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
AID1488617Antiproliferative activity against human SMMC7721 cells after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
AID174708Gastric cytoprotective activity in male wistar rat1997Journal of medicinal chemistry, Jun-06, Volume: 40, Issue:12
Structure-cytoprotective activity relationship of simple molecules containing an alpha,beta-unsaturated carbonyl system.
AID539681Inhibition of human recombinant CA9 catalytic domain by stopped-flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range.
AID1332531Immunopotentiating activity in splenic lymphocytes (unknown origin) assessed as effect on proliferation by measuring cell viability at 0.1 to 1 ug/ml pretreated followed by incubation of lymphocytes with ConA for 48 hrs by MTT assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and immunopotentiating activity of novel isoxazoline functionalized coumarins.
AID317243Inhibition of CK2 in rat liver2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships.
AID1874971Metabolic stability in human liver S9 fraction assessed as half life at 1 uM in presence of NADPH measured upto 60 min by LC-MS/MS analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.
AID1218610Detection of compound level in mouse hepatocytes treated with 25 uM of BMS-562086 after 3 hrs by HPLC analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist.
AID613474Cytotoxicity against mouse J774 cells at 100 uM by XTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives.
AID687443Gastric toxicity in Swiss mouse assessed as edema index at 60 mg/kg administered daily with single dose (Rvb = 0.6 +/- 0.2 edema index)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1327470Increase in glucose uptake in serum-starved mouse 3T3L1 adipocytes at 10 uM pretreated followed by glucose addition measured under basal condition by glucose oxidase peroxidase method2016European journal of medicinal chemistry, Oct-21, Volume: 122Total synthesis of 8-(6″-umbelliferyl)-apigenin and its analogs as anti-diabetic reagents.
AID1213489Activity at MRP4 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed phase-HPLC analysis in presence of GSH2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
AID1451414Half life in monkey hepatocytes2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
AID599335Antibacterial against Staphylococcus aureus ATCC 6538P at 20 mg/mL after 24 hrs by NCCLS M7-A6 method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin.
AID758230Inhibition of acetylcholinesterase (unknown origin) using acetylcholine iodide as substrate preincubated for 15 mins prior to substrate addition by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
New bioactive dihydrofuranocoumarins from the roots of the Tunisian Ferula lutea (Poir.) Maire.
AID256458Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 12 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID334650Toxicity in Salmonella Typhimurium T98 at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID607596Cytotoxicity against human PC3 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID1417122Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes after 72 hrs by Alamar Blue assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID607598Cytotoxicity against human LoVo cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID687429Toxicity in Swiss mouse assessed as corporal mass changes at 60 mg/kg, po dosed once daily for 7 days (Rvb = 0.58 +/- 0.03 g)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1347658Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Oxyprenylated Phenylpropanoids Bind to MT1 Melatonin Receptors and Inhibit Breast Cancer Cell Proliferation and Migration.
AID516863Inhibition kidney aldose reductase 2 by spectrophotometric analysis2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID553155Displacement of [3H]estradiol human recombinant 17beta-HSD2 expressed in Escherichia coli BL21 (DE3)-RIL at 0.6 uM by scintillation counting in presence of NAD+2011Journal of medicinal chemistry, Jan-13, Volume: 54, Issue:1
Synthesis and biological evaluation of (6- and 7-phenyl) coumarin derivatives as selective nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1.
AID1274834Inhibition of human carbonic anhydrase 12 catalytic domain by Stopped-Flow CO2 Hydrase assay2016Journal of medicinal chemistry, Jan-14, Volume: 59, Issue:1
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins.
AID1105459Antifungal activity against Aspergillus fumigatus ATCC 46913 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1451415Intrinsic clearance in rat hepatocytes assessed per 10'6 cells2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
AID392746Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation at 100 uM2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Synthesis of hydroxycoumarins and hydroxybenzo[f]- or [h]coumarins as lipid peroxidation inhibitors.
AID1488616Antiproliferative activity against human A549 cells after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
AID687417Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in hyperalgesia at 120 mg/kg, po dosed once daily for 7 days dosed 45 mins before PGE2 dosing measured 3 hrs post PGE2 challenge2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1451416Half life in rat hepatocytes2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
AID1665949Stability in mouse liver S9 fraction assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID376063Antimutagenic activity in Salmonella Typhimurium TA102 assessed as protection against hydrogen peroxide-induced mutation at 2 ug/plate after 2 days by modified Ames test1999Journal of natural products, Oct, Volume: 62, Issue:10
Umbelliferone analogues and their potential to inhibit Benzo(a)pyrene- and hydrogen peroxide-induced mutations.
AID1102098Stimulation of Phomopsis obscurans growth at 30 to 300 uM after 120 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID1376901Agonist activity at AhR (unknown origin) expressed in mouse H1L1.1c2 cells at 1 to 100 uM after 8 to 10 hrs by luciferase reporter gene assay2017Journal of natural products, 06-23, Volume: 80, Issue:6
Interaction of 7-Alkoxycoumarins with the Aryl Hydrocarbon Receptor.
AID336478Inhibition of COX2 at 100 uM by scintillation proximity assay2002Journal of natural products, Nov, Volume: 65, Issue:11
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
AID1451413Intrinsic clearance in monkey hepatocytes assessed per 10'6 cells2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
AID687414Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in hyperalgesia at 60 mg/kg, po dosed once daily for 7 days dosed 45 mins before carrageenan dosing measured 3 hrs post carrageenan challenge2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1349252Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in A549 cells assessed as reduction in viral titer after 24 to 48 hrs by hemagglutination test2017Journal of natural products, 12-22, Volume: 80, Issue:12
Regioselective IBX-Mediated Synthesis of Coumarin Derivatives with Antioxidant and Anti-influenza Activities.
AID400827In vivo antitumor activity against mouse P388 cells at 2.2 to 17.5 mg/kg
AID400828In vivo antitumor activity against mouse P388 cells at 1.4 to 11.4 mg/kg
AID1417094Inhibition of recombinant oligo-histidine-tagged Leishmania major DHODH expressed in Escherichia coli BL21(DE3) cells using DHO as substrate measured after 60 secs2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID1563157Intrinsic clearance in human hepatocytes assessed per 10'6 cells2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
(
AID1874970Inhibition of human placental cytosolic fraction 17beta-HSD1 at 1 uM using [3H]-E1 as substrate measured after 10 mins in presence of NADH by HPLC method2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.
AID613471Antiinflammatory activity in mouse J774 cells assessed as inhibition of LPS-induced IL-6 production at 100 uM by ELISA2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives.
AID1665944Stability in human plasma assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID539680Inhibition of full length human CA2 cytosolic isoform by stopped-flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range.
AID637775Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate at 500 uM after 60 mins by fluorescence quenching assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
AID1359334Inhibition of melanogenesis in mouse Melan-a cells assessed as effect on whitening property at 40 uM after 48 hrs2018European journal of medicinal chemistry, May-25, Volume: 152Natural oxyprenylated coumarins are modulators of melanogenesis.
AID758236Cytotoxicity against human HT-29 cells after 96 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
New bioactive dihydrofuranocoumarins from the roots of the Tunisian Ferula lutea (Poir.) Maire.
AID598386Inhibition of tyrosinase2011Bioorganic & medicinal chemistry letters, Jun-01, Volume: 21, Issue:11
New halogenated phenylcoumarins as tyrosinase inhibitors.
AID1332532Immunopotentiating activity in splenic lymphocytes (unknown origin) assessed as effect on proliferation by measuring cell viability at 0.1 to 1 ug/ml pretreated followed by incubation of lymphocytes with LPS for 48 hrs by MTT assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and immunopotentiating activity of novel isoxazoline functionalized coumarins.
AID687405Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in mechanical hyperalgesia at 30 to 120 mg/kg, po dosed 45 mins before complete Freund's adjuvant dosing measured 2 hrs post complete Freund's adjuvant challenge by elec2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID687430Toxicity in Swiss mouse assessed as liver weight changes per 10 gram of body weight at 60 mg/kg, po dosed once daily for 7 days (Rvb = 0.73 +/- 0.07 g/10 g body weight)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID613466Inhibition of LPS-stimulated iNOS protein expression in mouse J774 cells at 10 uM by RT-PCR analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives.
AID1252292Cytotoxicity against human ARPE19 cells assessed as cell viability up to 100 uM after 24 hrs by Cell Titer Blue assay2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
A multifunctional, light-activated prochelator inhibits UVA-induced oxidative stress.
AID256503Percent heme protein dependent lipid peroxidation at (0.1 mM) upon incubation for 10 min at 37 degree C. in pH 7.4 with arachidonic acid and H2O22005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID360659Inhibition of AChE by spectrophotometry2001Journal of natural products, May, Volume: 64, Issue:5
Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure-activity relationships.
AID687425Inhibition of complete Freund's adjuvant-induced neutrophil migration to paw tissue in Swiss mouse at 60 mg/kg, po dosed 45 mins before complete Freund's adjuvant dosing measured 3 to 4 hrs post complete Freund's adjuvant challenge by myeloperoxidase kine2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID613465Antiinflammatory activity in mouse J774 cells assessed as inhibition of LPS-induced NO production at 100 uM by Griess reaction2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives.
AID641823Inhibition of human full-length cytosolic CA1 after 6 hrs by stopped flow CO2 hydration assay2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
AID1274831Inhibition of human carbonic anhydrase 1 by Stopped-Flow CO2 Hydrase assay2016Journal of medicinal chemistry, Jan-14, Volume: 59, Issue:1
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins.
AID687442Gastric toxicity in Swiss mouse assessed as erosion index at 60 mg/kg administered daily with single dose (Rvb = 0 +/- 0 erosion index)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1105456Antifungal activity against Aspergillus flavus ATCC 16013 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1451418Half life in dog hepatocytes2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
AID1213508Activity at MRP2 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed phase-HPLC analysis in presence of GSH2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
AID1102110Stimulation of Colletotrichum gloeosporioides growth at 30 to 300 uM after 48 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID256452Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 0 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID376064Antimutagenic activity in Salmonella Typhimurium TA102 assessed as protection against hydrogen peroxide-induced mutation at 4 ug/plate after 2 days by modified Ames test1999Journal of natural products, Oct, Volume: 62, Issue:10
Umbelliferone analogues and their potential to inhibit Benzo(a)pyrene- and hydrogen peroxide-induced mutations.
AID1874968Inhibition of STS in human T47D cells using [3H]E1S as substrate measured after 24 hrs by HPLC analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.
AID687436Toxicity in Swiss mouse assessed as AST level at 60 mg/kg, po dosed once daily for 7 days (Rvb = 145.7 +/- 23.4 UI/L)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1874972Metabolic stability in mouse liver S9 fraction assessed as half life at 1 uM in presence of NADPH measured upto 60 min by LC-MS/MS analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.
AID1163511Cytotoxicity against human PANC1 cells under nutrient-rich condition after 24 hrs by WST8 dye based assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Synthesis and biological evaluation of isoprenylated coumarins as potential anti-pancreatic cancer agents.
AID607595Cytotoxicity against human A549 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID1274832Inhibition of human carbonic anhydrase 2 by Stopped-Flow CO2 Hydrase assay2016Journal of medicinal chemistry, Jan-14, Volume: 59, Issue:1
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins.
AID1265003Antioxidant activity assessed as DPPH radical scavenging activity2015European journal of medicinal chemistry, Dec-01, Volume: 106Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.
AID687431Toxicity in Swiss mouse assessed as kidney weight changes per 10 gram of body weight at 60 mg/kg, po dosed once daily for 7 days (Rvb = 0.06 +/- 0.00 g/10 g body weight)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1385469Antiausteritic activity against human MIAPaCa2 cells in nutrient-deprived medium measured after 24 hrs by WST8 assay2018Journal of natural products, 08-24, Volume: 81, Issue:8
Chemical Constituents of Thai Citrus hystrix and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line.
AID687406Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in mechanical hyperalgesia at 30 to 120 mg/kg, po dosed 45 mins before complete Freund's adjuvant dosing measured 6 hrs post complete Freund's adjuvant challenge by elec2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID754042Inhibition of equine serum BChE using S-butyrylthiocholine iodide as substrate preincubated for 6 mins prior to substrate addition measured at 60 to 180 seconds by Ellman's method2013European journal of medicinal chemistry, Jun, Volume: 64Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
AID687426Inhibition of carrageenan-induced neutrophil migration to paw tissue in Swiss mouse at 60 mg/kg, po dosed 45 mins before carrageenan dosing measured 3 to 4 hrs post complete Freund's adjuvant challenge by myeloperoxidase kinetic colorimetric assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID687432Toxicity in Swiss mouse assessed as heart weight changes per 10 gram of body weight at 60 mg/kg, po dosed once daily for 7 days (Rvb = 0.05 +/- 0.00 g/10 g body weight)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID256459Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 14 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID1899618Metabolic stability in human liver microsomes assessed as UGT-mediated metabolism at 20 uM and measured as half-life by LC-UV analysis2022European journal of medicinal chemistry, Jan-15, Volume: 228Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CL
AID683689Cytotoxicity against human U138MG cells incubated for 48 hrs by MTT assay2012European journal of medicinal chemistry, Nov, Volume: 57Selective cytotoxicity and apoptosis induction in glioma cell lines by 5-oxygenated-6,7-methylenedioxycoumarins from Pterocaulon species.
AID1347660Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Oxyprenylated Phenylpropanoids Bind to MT1 Melatonin Receptors and Inhibit Breast Cancer Cell Proliferation and Migration.
AID1874974Metabolic stability in mouse liver S9 fraction assessed as intrinsic clearance at 1 uM in presence of NADPH measured upto 60 min by LC-MS/MS analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.
AID1677485Inhibition of recombinant Staphylococcus aureus ATCC 6538p sortase A using dabcyl-LPETG-edans as substrate incubated for 2 hrs by fluorometric method2020Journal of natural products, 10-23, Volume: 83, Issue:10
Sortase A-Inhibitory Coumarins from the Folk Medicinal Plant
AID1332534Immunopotentiating activity in splenic lymphocytes (unknown origin) assessed as effect on proliferation by measuring cell viability at 10 ug/ml pretreated followed by incubation of lymphocytes with LPS for 48 hrs by MTT assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and immunopotentiating activity of novel isoxazoline functionalized coumarins.
AID687433Toxicity in Swiss mouse assessed as total leukocytes level at 60 mg/kg, po dosed once daily for 7 days (Rvb = 5.9 +/- 0.8 10'3/mL)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1218613Detection of compound level in cynomolgus monkey cryopreserved hepatocytes treated with 25 uM of BMS-562086 after 3 hrs by HPLC analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist.
AID1105455Antifungal activity against Aspergillus flavus LM 210 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1213506Activity at P-gp (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed-phase HPLC analysis in presence of ATP2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
AID1451420Half life in mouse hepatocytes2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
AID1563164Half-life in mouse hepatocytes2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
(
AID687441Gastric toxicity in Swiss mouse assessed as inflammatory cell index at 60 mg/kg administered daily with single dose (Rvb = 0.2 +/- 0.2 inflammatory cell index)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID599333Antibacterial against Bacillus cereus ATCC 11778 at 20 mg/mL after 24 hrs by NCCLS M7-A6 method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin.
AID1347664Antiproliferative activity against human MDA-MB-231 cells at 1 nM to 100 uM after 24 hrs by MTT assay relative to control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Oxyprenylated Phenylpropanoids Bind to MT1 Melatonin Receptors and Inhibit Breast Cancer Cell Proliferation and Migration.
AID255039Inhibitory concentration against soybean lipoxygenase upon incubation with sodium linoleate (0.1 mM) at RT2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID1138893Antiasthamic activity in Wistar rat tracheal ring assessed as reversal of carbachol-induced contraction at 0.1 to 500 uM relative to control2014European journal of medicinal chemistry, Apr-22, Volume: 77Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs.
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID256462Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 20 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID599336Antibacterial against Escherichia coli ATCC 8739 at 20 mg/mL after 24 hrs by NCCLS M7-A6 method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin.
AID1760262Inhibition of mushroom tyrosinase assessed as reduction in dopachrome formation using L-DOPA as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 20 mins by microplate reader analysis2020European journal of medicinal chemistry, Sep-01, Volume: 201Kojic acid-natural product conjugates as mushroom tyrosinase inhibitors.
AID334651Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1563161Half-life clearance in human hepatocytes2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
(
AID687419Inhibition of complete Freund's adjuvant-induced IL-1beta production in Swiss mouse at 60 mg/kg, po dosed 45 mins before complete Freund's adjuvant dosing measured up to 24 hrs post complete Freund's adjuvant challenge by ELISA2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1213509Activity at MRP3 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed phase-HPLC analysis in presence of GSH2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
AID1213501Activity at MRP1 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed-phase HPLC analysis in presence of ATP2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
AID553156Displacement of [3H]estradiol human recombinant 17beta-HSD2 expressed in Escherichia coli BL21 (DE3)-RIL at 6 uM by scintillation counting in presence of NAD+2011Journal of medicinal chemistry, Jan-13, Volume: 54, Issue:1
Synthesis and biological evaluation of (6- and 7-phenyl) coumarin derivatives as selective nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1.
AID1332533Immunopotentiating activity in splenic lymphocytes (unknown origin) assessed as effect on proliferation by measuring cell viability at 10 ug/ml pretreated followed by incubation of lymphocytes with ConA for 48 hrs by MTT assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and immunopotentiating activity of novel isoxazoline functionalized coumarins.
AID1665945Stability in human liver S9 fraction assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID1102095Stimulation of Diaporthe ampelina growth at 30 to 300 uM after 120 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID687423Inhibition of carrageenan-induced PGE2 production in Swiss mouse at 60 mg/kg, po dosed 45 mins before carrageenan dosing measured 3 hrs post carrageenan challenge by ELISA2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1349250Cytotoxicity against human A549 cells assessed as reduction in cell viability up to 120 ug/ml after 24 hrs by tryphan blue exclusion assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Regioselective IBX-Mediated Synthesis of Coumarin Derivatives with Antioxidant and Anti-influenza Activities.
AID1213505Activity at BCRP (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed-phase HPLC analysis in presence of ATP2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
AID1163510Cytotoxicity against human PANC1 cells under nutrient-deprived condition after 24 hrs by WST8 dye based assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Synthesis and biological evaluation of isoprenylated coumarins as potential anti-pancreatic cancer agents.
AID1218612Detection of compound level in beagle dog hepatocytes treated with 25 uM of BMS-562086 after 3 hrs by HPLC analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist.
AID758235Cytotoxicity against human MT4 cells after 96 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
New bioactive dihydrofuranocoumarins from the roots of the Tunisian Ferula lutea (Poir.) Maire.
AID754034Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay2013European journal of medicinal chemistry, Jun, Volume: 64Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
AID256464Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 24 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID1347662Antiproliferative activity against human MCF7 cells at 1 nM to 100 uM after 24 hrs by MTT assay relative to control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Oxyprenylated Phenylpropanoids Bind to MT1 Melatonin Receptors and Inhibit Breast Cancer Cell Proliferation and Migration.
AID1102112Stimulation of Colletotrichum acutatum growth at 30 uM after 48 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID392749Inhibition of soybean lipoxygenase by UV absorbance based assay2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Synthesis of hydroxycoumarins and hydroxybenzo[f]- or [h]coumarins as lipid peroxidation inhibitors.
AID493456Inhibition of human CA9 by CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
AID687444Gastric toxicity in Swiss mouse assessed as necrosis index at 60 mg/kg administered daily with single dose (Rvb = 0 +/- 0 necrosis index)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID256456Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 8 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID1105457Antifungal activity against Aspergillus flavus LM 247 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID207916Inhibitory activity against 5-alpha-reductase type 1 in cell culture system using LNCaP cells (androgen-sensitive human prostatic cancer cell line)2001Bioorganic & medicinal chemistry letters, Sep-03, Volume: 11, Issue:17
A novel class of inhibitors for steroid 5alpha-reductase: synthesis and evaluation of umbelliferone derivatives.
AID1347665Antiproliferative activity against human BT549 cells at 1 nM to 100 uM after 24 hrs by MTT assay relative to control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Oxyprenylated Phenylpropanoids Bind to MT1 Melatonin Receptors and Inhibit Breast Cancer Cell Proliferation and Migration.
AID641824Inhibition of human full-length cytosolic CA2 after 6 hrs by stopped flow CO2 hydration assay2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
AID294445Inhibition of xanthine oxidase2007European journal of medicinal chemistry, Jul, Volume: 42, Issue:7
Relationship between quantum-chemical descriptors of proton dissociation and experimental acidity constants of various hydroxylated coumarins. Identification of the biologically active species for xanthine oxidase inhibition.
AID1252288Induction of Fe-dependent reactive oxygen species formation after 90 mins by H2DCF-DA-based fluorescence assay2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
A multifunctional, light-activated prochelator inhibits UVA-induced oxidative stress.
AID1385471Cytotoxicity against human PANC1 cells in DMEM measured after 24 hrs by WST8 assay2018Journal of natural products, 08-24, Volume: 81, Issue:8
Chemical Constituents of Thai Citrus hystrix and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line.
AID256502Percent heme protein dependent lipid peroxidation at (1 mM) upon incubation for 10 min at 37 degree C. in pH 7.4 with arachidonic acid and H2O22005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID1349249Cytotoxicity against human A549 cells assessed as reduction in cell viability up to 120 ug/ml after 24 hrs by microscopic analysis2017Journal of natural products, 12-22, Volume: 80, Issue:12
Regioselective IBX-Mediated Synthesis of Coumarin Derivatives with Antioxidant and Anti-influenza Activities.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID376058Antimutagenic activity in Salmonella Typhimurium TA100 assessed as protection against benzo[a]pyrene-induced mutation at 8 ug/plate after 2 days by modified Ames test1999Journal of natural products, Oct, Volume: 62, Issue:10
Umbelliferone analogues and their potential to inhibit Benzo(a)pyrene- and hydrogen peroxide-induced mutations.
AID376065Antimutagenic activity in Salmonella Typhimurium TA102 assessed as protection against hydrogen peroxide-induced mutation at 8 ug/plate after 2 days by modified Ames test1999Journal of natural products, Oct, Volume: 62, Issue:10
Umbelliferone analogues and their potential to inhibit Benzo(a)pyrene- and hydrogen peroxide-induced mutations.
AID1138894Antiasthamic activity in Wistar rat tracheal ring assessed as reversal of carbachol-induced contraction2014European journal of medicinal chemistry, Apr-22, Volume: 77Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs.
AID256463Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 22 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID758237Cytotoxicity against human HCT116 cells after 96 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
New bioactive dihydrofuranocoumarins from the roots of the Tunisian Ferula lutea (Poir.) Maire.
AID216186The compound was tested for antiviral activity against Herpes simplex virus type-1 in the vero cells using plaque inhibition assay; no IC50 reached without damage to the cell monolayer.1999Journal of medicinal chemistry, Aug-26, Volume: 42, Issue:17
Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds.
AID687412Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in paw edema at 60 mg/kg, po dosed once daily for 7 days dosed 45 mins before complete Freund's adjuvant dosing measured post complete Freund's adjuvant challenge2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID687404Effect on baseline nociceptive threshold in Swiss mouse inflammatory pain model at 30 to 120 mg/kg, po dosed 45 mins before complete Freund's adjuvant dosing measured 4 to 24 hrs post complete Freund's adjuvant challenge by electronic pressure-meter test2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID607594Cytotoxicity against human OE21 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID687410Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in paw withdrawal response at 60 mg/kg, po dosed once daily for 7 days dosed 45 mins before complete Freund's adjuvant dosing measured 2 days post compound withdrawal2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID754041Selectivity index, ratio of IC50 for equine serum BChE to IC50 for electric eel AChE2013European journal of medicinal chemistry, Jun, Volume: 64Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
AID607597Cytotoxicity against human SK-MEL-28 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID1105460Antifungal activity against Aspergillus fumigatus IPP 210 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID613470Antiinflammatory activity in mouse J774 cells assessed as inhibition of LPS-induced IL-6 production at 10 uM by ELISA2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives.
AID493454Inhibition of human CA1 by CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
AID622339Cytotoxicity against human PANC1 cells in nutrient-deprived condition up to 200 uM after 24 hrs by WST-8 assay2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative.
AID256461Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 18 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID1105454Antifungal activity against Aspergillus flavus LM 26 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID309363Antiinflammatory activity in CD1 mouse assessed as inhibition of croton oil-induced ear oedema at 0.3 umol/cm^2 after 6 hrs2007Bioorganic & medicinal chemistry letters, Oct-15, Volume: 17, Issue:20
Synthesis and anti-inflammatory activity of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives.
AID493455Inhibition of human CA2 by CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
AID392748Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw edema at 0.01 mmol/kg, ip after 3.5 hrs2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Synthesis of hydroxycoumarins and hydroxybenzo[f]- or [h]coumarins as lipid peroxidation inhibitors.
AID348892Antioxidant activity assessed as DPPH free radical scavenging activity after 20 mins2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
Synthesis and free radical scavenging activity of some new spiropyranocoumarins.
AID607600Induction of human U373 cell death assessed as morphological changes at MTT assay-related IC50 after 72 hrs by quantitative video microscopy2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID1893727Metabolic stability in CD-1 mouse liver S9 fraction assessed as half life at 1 micromol/L in presence of UDPGA measured upto 24 hrs by LC-MS/MS analysis
AID1893725Metabolic stability in human liver S9 fraction assessed as half life at 1 micromol/L in presence of UDPGA measured upto 24 hrs by LC-MS/MS analysis
AID1563159Intrinsic clearance in dog hepatocytes assessed per 10'6 cells2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
(
AID1376904Antagonist activity at AhR (unknown origin) expressed in mouse H1L1.1c2 cells assessed as inhibition of FICZ-induced AhR activation at 1 to 100 uM after 8 to 10 hrs by luciferase reporter gene assay2017Journal of natural products, 06-23, Volume: 80, Issue:6
Interaction of 7-Alkoxycoumarins with the Aryl Hydrocarbon Receptor.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1417130Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 trypomastigotes after 72 hrs by Alamar Blue assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID256460Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 16 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID553154Displacement of [3H]estrone human recombinant 17beta-HSD1 expressed in Escherichia coli BL21 (DE3)-RIL at 6 uM by scintillation counting in presence of NADPH2011Journal of medicinal chemistry, Jan-13, Volume: 54, Issue:1
Synthesis and biological evaluation of (6- and 7-phenyl) coumarin derivatives as selective nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1.
AID256455Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 6 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID624616Specific activity of expressed human recombinant UGT2B152000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1563160Intrinsic clearance in mouse hepatocytes assessed per 10'6 cells2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
(
AID1451417Intrinsic clearance in dog hepatocytes assessed per 10'6 cells2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
AID516865Selectivity index, ratio of IC50 for sorbitol dehydrogenase to IC50 for kidney aldose reductase 22010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID641825Inhibition of human recombinant CA9 after 6 hrs by stopped flow CO2 hydration assay2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
AID758224Antioxidant activity assessed as DPPH free radical scavenging activity by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
New bioactive dihydrofuranocoumarins from the roots of the Tunisian Ferula lutea (Poir.) Maire.
AID687416Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in hyperalgesia at 60 mg/kg, po dosed once daily for 7 days dosed 45 mins before PGE2 dosing measured 3 hrs post PGE2 challenge2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID624608Specific activity of expressed human recombinant UGT1A42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID348893Antioxidant activity assessed as inhibition of xanthine-xanthine oxidase generated superoxide anion radical production at 0.5 mM2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
Synthesis and free radical scavenging activity of some new spiropyranocoumarins.
AID1347663Antiproliferative activity against mouse mammary carcinoma cell at 1 nM to 100 uM after 24 hrs by MTT assay relative to control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Oxyprenylated Phenylpropanoids Bind to MT1 Melatonin Receptors and Inhibit Breast Cancer Cell Proliferation and Migration.
AID622344Cytotoxicity against human PANC1 cells in nutrient-rich condition assessed as cell death up to 200 uM after 24 hrs by WST-8 assay2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative.
AID1102103Stimulation of Botryotinia fuckeliana growth at 30 to 300 uM after 48 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID1347661Antiproliferative activity against human BT549 cells after 24 hrs by MTT assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Oxyprenylated Phenylpropanoids Bind to MT1 Melatonin Receptors and Inhibit Breast Cancer Cell Proliferation and Migration.
AID1874973Metabolic stability in human liver S9 fraction assessed as intrinsic clearance at 1 uM in presence of NADPH measured upto 60 min by LC-MS/MS analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.
AID75720Inhibitory concentration against glyceraldehyde-3-phosphate dehydrogenase was determined as log 1/IC502004Bioorganic & medicinal chemistry letters, May-03, Volume: 14, Issue:9
Structure-activity relationships of novel inhibitors of glyceraldehyde-3-phosphate dehydrogenase.
AID1385468Antiausteritic activity against human PANC1 cells in nutrient-deprived medium measured after 24 hrs by WST8 assay2018Journal of natural products, 08-24, Volume: 81, Issue:8
Chemical Constituents of Thai Citrus hystrix and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line.
AID256453Onset of arthritis measured as arthritic score at i.p. dose of 0.001 m mol/kg in rats injected intradermally with Freund's adjuvant after 2 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID1665948Stability in mouse plasma assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID399963Cytotoxicity against HUVEC2004Journal of natural products, Mar, Volume: 67, Issue:3
Anthrone and oxanthrone C-glycosides from Picramnia latifolia collected in Peru.
AID516862Inhibition human recombinant aldose reductase 1 by spectrophotometric analysis2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID392742Antioxidant activity assessed as DPPH radical scavenging activity at 0.05 mM after 20 mins2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Synthesis of hydroxycoumarins and hydroxybenzo[f]- or [h]coumarins as lipid peroxidation inhibitors.
AID599330Antibacterial against Micrococcus luteus ATCC 9341 at 20 mg/mL after 24 hrs by NCCLS M7-A6 method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin.
AID607593Cytotoxicity against human U373 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID1213502Activity at MRP2 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed-phase HPLC analysis in presence of ATP2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
AID392743Antioxidant activity assessed as DPPH radical scavenging activity at 0.05 mM after 60 mins2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Synthesis of hydroxycoumarins and hydroxybenzo[f]- or [h]coumarins as lipid peroxidation inhibitors.
AID1693051Metabolic stability in human liver microsomes assessed as half life in Phase II metabolic system at 10 uM measured by LC-UV method2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors.
AID683688Cytotoxicity against rat C6 cells incubated for 48 hrs by MTT assay2012European journal of medicinal chemistry, Nov, Volume: 57Selective cytotoxicity and apoptosis induction in glioma cell lines by 5-oxygenated-6,7-methylenedioxycoumarins from Pterocaulon species.
AID1348311Inhibition of human carbonic anhydrase 1 incubated for 15 mins prior to testing by stopped-flow CO2 hydration assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
AID1348312Inhibition of human carbonic anhydrase 2 incubated for 15 mins prior to testing by stopped-flow CO2 hydration assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
AID1218614Detection of compound level in human cryopreserved hepatocytes treated with 25 uM of BMS-562086 after 3 hrs by HPLC analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist.
AID1488618Antiproliferative activity against human 293T cells after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
AID687420Inhibition of complete Freund's adjuvant-induced TNFalpha production in Swiss mouse at 60 mg/kg, po dosed 45 mins before complete Freund's adjuvant dosing measured up to 2 hrs post complete Freund's adjuvant challenge by ELISA2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID1488615Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
AID399960Cytotoxicity against human Lu1 cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Anthrone and oxanthrone C-glycosides from Picramnia latifolia collected in Peru.
AID392741Antioxidant activity assessed as superoxide radical scavenging activity at 100 uM by nitroblue tetrazolium method2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Synthesis of hydroxycoumarins and hydroxybenzo[f]- or [h]coumarins as lipid peroxidation inhibitors.
AID1385472Cytotoxicity against human MIAPaCa2 cells in DMEM measured after 24 hrs by WST8 assay2018Journal of natural products, 08-24, Volume: 81, Issue:8
Chemical Constituents of Thai Citrus hystrix and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line.
AID256490Percent change in body weight of (FA) adjuvant induced rats at i.p. dose of 0.001 m mol/kg after 24 days2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID599334Antibacterial against Staphylococcus aureus ATCC 6538 at 20 mg/mL after 24 hrs by NCCLS M7-A6 method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin.
AID1665946Stability in rat plasma assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID613464Antiinflammatory activity in mouse J774 cells assessed as inhibition of LPS-induced NO production at 10 uM by Griess reaction2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives.
AID376059Antimutagenic activity in Salmonella Typhimurium TA100 assessed as protection against benzo[a]pyrene-induced mutation at 16 ug/plate after 2 days by modified Ames test1999Journal of natural products, Oct, Volume: 62, Issue:10
Umbelliferone analogues and their potential to inhibit Benzo(a)pyrene- and hydrogen peroxide-induced mutations.
AID687434Toxicity in Swiss mouse assessed as creatinine level at 60 mg/kg, po dosed once daily for 7 days (Rvb = 0.26 +/- 0.05 mg/dL)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID400826Cytotoxicity against mouse P388 cells
AID1706382Metabolic stability at phase 2 in human liver microsomes assessed as half life at 10 uM by LC-MS/MS analysis2021European journal of medicinal chemistry, Jan-01, Volume: 209Design, synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors.
AID1385473Cytotoxicity against human PSN1 cells in DMEM measured after 24 hrs by WST8 assay2018Journal of natural products, 08-24, Volume: 81, Issue:8
Chemical Constituents of Thai Citrus hystrix and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line.
AID1252289Cytoprotective activity in human ARPE19 cells assessed as reduction of UVA radiation-mediated cell death at 5 to 100 uM preincubated for 2 hrs followed by 40 mins UVA irradiation measured after 5 hrs by LDH release assay2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
A multifunctional, light-activated prochelator inhibits UVA-induced oxidative stress.
AID1105458Antifungal activity against Aspergillus fumigatus ATCC 40640 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1451419Intrinsic clearance in mouse hepatocytes assessed per 10'6 cells2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
AID613473Inhibition of LPS-stimulated COX2 protein expression in mouse J774 cells at 100 uM by chemiluminescence assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives.
AID1563158Intrinsic clearance in rat hepatocytes assessed per 10'6 cells2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
(
AID624607Specific activity of expressed human recombinant UGT1A32000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1451412Half life in human hepatocytes2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
AID256359Percent inhibition of carrageenan 2% (0.1 mL intradermal) induced paw edema at the i.p. dose of 0.01 m mol/kg in fisher 344 rats; n=5; no action2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID1348313Inhibition of human carbonic anhydrase 9 incubated for 15 mins prior to testing by stopped-flow CO2 hydration assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
AID539679Inhibition of full length human CA1 cytosolic isoform by stopped-flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range.
AID395316Inhibition of Trypanosoma cruzi recombinant glycosomal GAPDH expressed in Escherichia coli by spectrophotometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
AID1274833Inhibition of human carbonic anhydrase 9 catalytic domain by Stopped-Flow CO2 Hydrase assay2016Journal of medicinal chemistry, Jan-14, Volume: 59, Issue:1
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins.
AID624614Specific activity of expressed human recombinant UGT2A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1349253Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in A549 cells assessed as reduction in viral titer at 120 ug/ml after 24 to 48 hrs by hemagglutination test relative to control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Regioselective IBX-Mediated Synthesis of Coumarin Derivatives with Antioxidant and Anti-influenza Activities.
AID687435Toxicity in Swiss mouse assessed as ALT level at 60 mg/kg, po dosed once daily for 7 days (Rvb = 68.0 +/- 12.8 UI/L)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.
AID493457Inhibition of human CA12 by CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
AID1348314Inhibition of human carbonic anhydrase 12 incubated for 15 mins prior to testing by stopped-flow CO2 hydration assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
AID539682Inhibition of human recombinant CA12 catalytic domain by stopped-flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range.
AID1451411Intrinsic clearance in human hepatocytes assessed per 10'6 cells2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
AID355880Pesticidal activity against Dermatophagoides pteronyssinus after 24 hrs2003Journal of natural products, May, Volume: 66, Issue:5
Acaricidal activity of tonka bean extracts. Synthesis and structure-activity relationships of bioactive derivatives.
AID553153Displacement of [3H]estrone human recombinant 17beta-HSD1 expressed in Escherichia coli BL21 (DE3)-RIL at 0.6 uM by scintillation counting in presence of NADPH2011Journal of medicinal chemistry, Jan-13, Volume: 54, Issue:1
Synthesis and biological evaluation of (6- and 7-phenyl) coumarin derivatives as selective nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1.
AID1213504Activity at MRP4 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed-phase HPLC analysis in presence of ATP2012Drug metabolism and disposition: the biological fate of chemicals, Jun, Volume: 40, Issue:6
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
AID373105Antiamnesic activity against Entamoeba histolytica HM1:IMSS after 72 hrs by microdilution method2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Antiamoebic coumarins from the root bark of Adina cordifolia and their new thiosemicarbazone derivatives.
AID516866Selectivity index, ratio of IC50 for human recombinant aldose reductase 1 to IC50 for kidney aldose reductase 22010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID399961Cytotoxicity against human LNCAP cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Anthrone and oxanthrone C-glycosides from Picramnia latifolia collected in Peru.
AID613467Inhibition of LPS-stimulated iNOS protein expression in mouse J774 cells at 100 uM by RT-PCR analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives.
AID256506Superoxide radical scavenging activity at 1 mM upon incubation for 2 min at RT in pH 7.4 with PMS, NADH and NBT by nitroblue tetrazolium method2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Synthesis and antiinflammatory activity of coumarin derivatives.
AID144377Ability to induce NAD(P)H quinone reductase activity in cultured Hepa 1c1c7 murine hepatoma cells.1998Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers.
AID1665947Stability in rat liver S9 fraction assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID1589934Half life in human S9 fraction2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Lead generation of 1,2-dithiolanes as exon 19 and exon 21 mutant EGFR tyrosine kinase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1799899NS5B Inhibition Assay from Article 10.1111/cbdd.12105: \\Evaluation of Coumarin and Neoflavone Derivatives as HCV NS5B Polymerase Inhibitors.\\2013Chemical biology & drug design, May, Volume: 81, Issue:5
Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (477)

TimeframeStudies, This Drug (%)All Drugs %
pre-199039 (8.18)18.7374
1990's85 (17.82)18.2507
2000's119 (24.95)29.6817
2010's196 (41.09)24.3611
2020's38 (7.97)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.35 (24.57)
Research Supply Index6.22 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index74.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (1.61%)5.53%
Reviews10 (2.02%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other478 (96.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]